Company China Isotope & Radiation Corporation

Equities

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 09:09:00 03/05/2024 BST 5-day change 1st Jan Change
10.96 HKD -0.72% Intraday chart for China Isotope & Radiation Corporation +1.29% -17.96%

Business Summary

China Isotope & Radiation Corporation is a China-based company mainly engaged in research, development, manufacturing and sales of radiopharmaceuticals and radioactive source products. The Company operates mainly through five segments. The Pharmaceuticals segment is mainly engaged in the manufacture and sales of various radiopharmaceuticals for imaging diagnosis and treatment, urea breath test kits and testers, as well as in vitro diagnostic reagents and kits. The Radioactive Source Product segment is mainly engaged in the production and sales of various radioactive source products, and provides related technical services. The Irradiation segment mainly provides irradiation sterilization services and others. The Radiotherapy Equipment and Related Services segment is mainly engaged in the research and development of radiotherapy equipment. The Independent Medical Laboratory Services and Other Business segment mainly provides independent medical laboratory services.

Number of employees: 3,105

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceuticals
62.2 %
4,562 63.8 % 4,562 62.2 % -0.00%
Radiation Therapy Equipments and Related Services
14.1 %
851 11.9 % 1,032 14.1 % +21.18%
Other Business
12.3 %
866 12.1 % 901 12.3 % +4.02%
Radioactive Source Products
8.8 %
676 9.5 % 648 8.8 % -4.11%
Irradiation
2.6 %
192 2.7 % 189 2.6 % -1.45%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
7,147 100.0 % 7,332 100.0 % +2.58%

Managers

Managers TitleAgeSince
Director/Board Member 54 30/04/16
Director/Board Member 59 -
Director/Board Member 53 28/07/22
Comptroller/Controller/Auditor 50 31/10/20
Comptroller/Controller/Auditor 50 17/12/15
Corporate Secretary 57 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 53 28/07/22
Director/Board Member 57 29/12/20
Director/Board Member 59 -
Director/Board Member 55 21/02/17
Director/Board Member 52 27/06/19
Director/Board Member 52 29/12/19
Director/Board Member 73 29/12/19
Director/Board Member - 25/03/20
Director/Board Member 55 24/02/21
Director/Board Member 44 24/02/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 239,906,100 237,507,039 ( 99.00 %) 0 91.21 %
Stock B 1 79,968,800 54,252,600 ( 67.84 %) 0

Shareholders

NameEquities%Valuation
Hong Bo Li
21.02 %
16,809,800 21.02 % 22 M $
9,516,600 11.90 % 12 M $
8,006,000 10.01 % 10 M $
Serenity Capital Management Ltd. (Cayman Islands)
6.004 %
4,801,600 6.004 % 6 M $
Invesco Canada Ltd.
5.537 %
4,427,600 5.537 % 6 M $
UBS Asset Management Switzerland AG
4.622 %
3,696,257 4.622 % 5 M $
Invesco Hong Kong Ltd.
4.231 %
3,383,600 4.231 % 4 M $
Invesco Advisers, Inc.
2.772 %
2,216,800 2.772 % 3 M $
Lacuna Vermögen GmbH
0.3376 %
270,000 0.3376 % 348 435 $
Dimensional Fund Advisors Ltd.
0.0413 %
33,042 0.0413 % 42 641 $
NameEquities%Valuation
China State-Owned Assets Supervision & Admn Commission
54.45 %
130,620,563 54.45 % 169 M $
China Institute of Atomic Energy Foundation
24.40 %
58,534,835 24.40 % 76 M $
Nuclear Power Institute of China
19.59 %
46,994,835 19.59 % 61 M $

Company contact information

China Isotope & Radiation Corp.

No. 66 Changwa Middle Street

100045, Beijing

+86 10 6851 5220

http://www.china-isotope.com
address China Isotope & Radiation Corporation(1763)
  1. Stock Market
  2. Equities
  3. 1763 Stock
  4. Company China Isotope & Radiation Corporation